Fulcrum Therapeutics, Inc. (FULC)
11.47
+0.13
(+1.15%)
USD |
NASDAQ |
Dec 31, 11:22
Fulcrum Therapeutics Market Cap: 620.74M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agios Pharmaceuticals, Inc. | 1.594B |
| Biogen, Inc. | 25.71B |
| CorMedix, Inc. | 956.50M |
| Apellis Pharmaceuticals, Inc. | 3.181B |
| NovaBay Pharmaceuticals, Inc. | 718.26M |
Market Cap Related Metrics
| PEG Ratio | -0.0347 |
| Price to Book Value | 3.129 |
| Price | 11.47 |
| Earnings Yield | -10.28% |
| PEGY Ratio | -0.0347 |